Avaliação da segurança e potencial bioativo de nanopartículas de carotenoides oriundo de melão Cantaloupe (Cucumis melo L.) administradas em modelo experimental de inflamação crônica

Carotenoids have powerful anti-inflammatory action on the human body. However, are unstable in the presence of light, acids, oxygen, and heat, which can lead to the loss of antioxidant effects related to the consumption of these molecules. Nanoencapsulation appears as a strategy to preserve or en...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Autor principal: Medeiros, Isaiane
Outros Autores: Morais, Ana Heloneida de Araújo
Formato: Dissertação
Idioma:pt_BR
Publicado em: Universidade Federal do Rio Grande do Norte
Assuntos:
Endereço do item:https://repositorio.ufrn.br/jspui/handle/123456789/30033
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
Descrição
Resumo:Carotenoids have powerful anti-inflammatory action on the human body. However, are unstable in the presence of light, acids, oxygen, and heat, which can lead to the loss of antioxidant effects related to the consumption of these molecules. Nanoencapsulation appears as a strategy to preserve or enhance the antiinflammatory action, in addition to increasing the solubility and bioavailability of carotenoids. Therefore, it is necessary to evaluate the safety of nanoparticles for future clinical applications. Thus, the objective of this study was to evaluate the safety and bioactivity of nanoparticles based on crude Cantaloupe melon extract rich in carotenoids and porcine gelatin in Wistar rats. Encapsulation was performed by oil/water emulsification followed by freeze-drying, and porcine gelatin was used as an encapsulating agent, and Tween 20 as a surfactant. Nanoformulation (EPG) was characterized by different physical and chemical analyzes and evaluated for efficiency of incorporation (EI). Toxicity was investigated through signs of general toxicity, body weight and food consumption in male Wistar rats fed with a high glycemic index and glycemic load (HGLI) diet treated with EPG administered by gavage (50 mg/kg, n = 5), and crude extract rich in carotenoid (CE) (12.5 mg/kg, n = 5) for ten days, using as controls a group without treatment (n = 5) and another treated with a standard diet (n = 5). Blood toxicity (blood count, fasting blood glucose, triglycerides, total cholesterol, liver, and kidney function), morphology and histopathology of the liver, small intestine, kidneys, stomach, and spleen, were evaluated. The characterization of EPG pointed to the presence of spherical particles with a smooth surface, an average diameter of 74 (12.7) nm, a polydispersion index of 0.53 (0.12), and EI of 98% (1.78). For signs of general toxicity, there was no significant difference (p> 0.05) between the initial and final weight of the rats in each evaluated group. There was a significant increase (p <0.05) of 23% in food consumption only in the group without treatment. The biochemical parameters analyzed evidenced low toxicity of EPG. The results obtained for the determination of the relative weight of the livers, spleen, small intestine, kidneys, and stomach showed that there was no significant difference (p> 0.05) between the studied groups. The morphological and histopathological analyzes of the liver showed acute hepatitis in the animals of all the evaluated groups, and those treated with CE and EPG showed improved tissue aspects. For small intestine, chronic enteritis was observed in all animals, with an improvement in the aspect of the animals' villi and intestinal glands treated with EPG. The stomach, spleen, and kidneys do not present a histopathological alteration. Spearman (r) correlations and p-value of the histopathological parameters analyzed semiquantitatively corroborated with the aspects of the histopathological slides. The results suggest the safe application of EPG and a bioactive effect, possibly related to the anti-inflammatory potential, showing the safety regarding the use in future clinical studies, aiming to investigate the efficacy in the control of inflammatory processes.